News story
20 June 2023
Addenbrooke’s Charitable Trust is proud to be supporting an international study, led by Addenbrooke’s Hospital with its search to find drugs that protect the most vulnerable patients from Covid.
COVID-19 continues to have devastating consequences around the world, particularly for the most vulnerable. The aim of study ‘PROTECT-V’ is to discover drugs to help individuals with kidney problems, those receiving drugs that suppress the immune system due to an organ transplant or an autoimmune disease, receiving cancer treatment, or with immunodeficiency.
Addenbrooke’s Charitable Trust chief executive, Shelly Thake, commented: “ACT is proud to support world-leading research taking place across Addenbrooke’s, and we were delighted that our supporters’ donations have contributed to a study which has sowed the seeds for more important work in the fight against COVID-19.”
To read more about this amazing work please visit the Addenbrooke’s website. You can also learn about other vital research funded by ACT to improve patient care at Addenbrooke’s and across the NHS here.
Return to news